We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 25

A patent landscape analysis: iPSCs

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • May 16 2013

There are several emerging technology clusters in the induced pluripotent stem cell (iPSC) space. Simon Elliot and I conducted a patent landscape

Patent exhaustion and self-replicating technologies

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • May 13 2013

Today in Bowman v. Monstanto Co., 569 U.S. __ (2013), a unanimous Supreme Court held that under the doctrine of patent exhaustion,the authorized sale

Video interview: discussing the Supreme Court’s oral arguments in Myriad gene patenting case

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 25 2013

Earlier this week, I had the opportunity to speak again with Colin O'Keefe of LXBN regarding last week's oral arguments in Association for Molecular

Personalized medicine and the gene patenting debate

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 15 2013

The transcript for today's Supreme Court oral argument in The Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398 (2013) has

“Human genes” and patents

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 14 2013

At 10:00 A.M. on April 15th, the U.S. Supreme Court will entertain oral arguments in the dispute now known as the human "gene patenting" case. The

A cautionary tale for patent applicants

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 2 2013

When should a patent application be filed ? Should it be filed prior to submission of a manuscript or abstract for peer-review or just prior to

Petitioners file Supreme Court “gene patenting” brief

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • January 25 2013

Petitioners (The Association for Molecular Pathology et al., represented by the American Civil Liberties Union or "Petitioner" or "ACLU") filed their

Personalized medicine patenting update

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • January 13 2013

Patenting diagnostic methods is more challenging in the wake of the U.S. Supreme Courts Mayo Collaborative Services v. Prometheus Laboratories, Inc

Video interview: discussing Myriad & the Supreme Court with LXBN TV

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • December 14 2012

Following up on my post examining the Myriad gene patenting case, which is heading to the Supreme Court, I had the chance to discuss the subject with Colin O’Keefe of LXBN

Are human genes patentable?

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • December 11 2012

As reported in my November 30th, 2012 post, the U.S. Supreme Court granted certiorari to review the issue “are human genes patentable?”